Manufactured by:ProteoGenix
Save 20%RUO

Anti-Human CD26/DPP4 Antibody (BT 5/9)

Anti-Human CD26/DPP4 Antibody (BT 5/9) from ProteoGenix; catalogue ARO-A23013; research use only.

SKU:
ABM121072-1
Manufacturer SKU
ARO-A23013
Product type
Primary Antibodies
TargetADABP, ADCP-2, ADCP2, Adenosine deaminase complexing protein 2, CD26, DPP IV, DPP4, Dipeptidyl peptidase 4, Dipeptidyl peptidase 4 membrane form, Dipeptidyl peptidase 4 soluble form, Dipeptidyl peptidase IV, Dipeptidyl peptidase IV membrane form, Dipeptidyl peptidase IV soluble form, EC:3.4.14.5, T-cell activation antigen CD26, TP103
ApplicationsFunctional Assay, ELISA, Flow Cytometry
Species / reactivityHuman

Manufacturer provenance

Manufactured by:
ProteoGenix
Sold by:
ABMIUM
Fulfilled from:
Manufacturer facility or confirmed fulfilment location

Know who made it. See the evidence. Buy through one marketplace.

Product description

Anti-Human CD26/DPP4 Antibody (BT 5/9) – Targeting DPP4 for Enhanced Biomedical Research

Introduction

The Anti-Human CD26/DPP4 Antibody (BT 5/9) is a highly specific and reliable tool for targeting the DPP4 protein. This antibody is produced using advanced biotechnology techniques and has been extensively validated for its effectiveness in various research applications. With its ability to specifically bind to DPP4, this antibody offers a valuable tool for scientists and researchers in the field of biomedicine.

Biological Function

DPP4, also known as CD26, is a cell surface glycoprotein that plays a crucial role in various physiological processes. It is involved in the regulation of immune response, glucose metabolism, and cell signaling pathways. DPP4 has also been identified as a potential therapeutic target for various diseases, making it a key protein of interest in biomedical research.

Main Applications

The Anti-Human CD26/DPP4 Antibody (BT 5/9) is primarily used for detecting and quantifying DPP4 expression in various biological samples. It can be used in techniques such as flow cytometry, immunohistochemistry, and western blotting. This antibody can also be used for functional studies to understand the role of DPP4 in different cellular processes.

Experimental Use Cases

The Anti-Human CD26/DPP4 Antibody (BT 5/9) has been extensively used in research studies related to diabetes, cancer, and immune disorders. In a study on diabetes, this antibody was used to investigate the role of DPP4 in the regulation of glucose metabolism. In another study on cancer, it was used to assess the expression of DPP4 in tumor tissues. Additionally, this antibody has been used in studies on immune disorders to understand the role of DPP4 in immune response regulation.

This antibody has been specifically designed and validated for its ability to target DPP4, making it a valuable tool for researchers studying this protein. With its high specificity and reliability, the Anti-Human CD26/DPP4 Antibody (BT 5/9) offers accurate and consistent results in various research applications.

Structure

To summarize, the Anti-Human CD26/DPP4 Antibody (BT 5/9) is a highly specific and reliable tool for targeting the DPP4 protein. Its main applications include detecting and quantifying DPP4 expression, as well as functional studies to understand its role in different cellular processes. With its proven effectiveness in various research studies, this antibody is an essential tool for scientists and researchers in the field of biomedicine.

ProteoGenix catalogue number ARO-A23013. For research use only.

Target: ADABP, ADCP-2, ADCP2, Adenosine deaminase complexing protein 2, CD26, DPP IV, DPP4, Dipeptidyl peptidase 4, Dipeptidyl peptidase 4 membrane form, Dipeptidyl peptidase 4 soluble form, Dipeptidyl peptidase IV, Dipeptidyl peptidase IV membrane form, Dipeptidyl peptidase IV soluble form, EC:3.4.14.5, T-cell activation antigen CD26, TP103; Clonality: Monoclonal Antibody; Reactivity: Human; Applications: Functional assay, ELISA, Flow Cyt.

Available configurations: 50ug, 100ug, 1mg.

Download the manufacturer datasheet

Key facts & specifications
Also known as
Anti-ADABP, ADCP-2, ADCP2, Adenosine deaminase complexing protein 2, CD26, DPP IV, DPP4, Dipeptidyl peptidase 4, Dipeptidyl peptidase 4 membrane form, Dipeptidyl peptidase 4 soluble form, Dipeptidyl peptidase IV, Dipeptidyl peptidase IV membrane form, Dipeptidyl peptidase IV soluble form, EC:3.4.14.5, T-cell activation antigen CD26, TP103
Clonality
Monoclonal
Validation & performance evidence
ABMIUM Validated™ ABMIUM Verified™ Expected performance Not suitable

Application validation

Evidence status by application and model.

SpeciesWBIHC-PIHC-FrIF/ICCFlow CytIPChIPELISAFunctional assay
Human
Identifiers & database references
Manufacturer SKU
ARO-A23013
Storage, stability & shipping
Storage conditions
4°C for short term (1 week), store at -20°C to -80°C for long term(1 year); Avoid repeated freeze-thaw cycles
Shipped at
Blue ice (+4°C)
Compliance & documents
ISO certifications
ISO 9001:2023, ISO 14001: 2023
Datasheet
Open datasheet
Frequently asked questions
Who manufactured this product?

This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.

Can ABMIUM ship this product internationally?

ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.

Can I check suitability before ordering?

Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.

Is this product for clinical use?

Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.

ProteoGenix
£235.00£188.00